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Purpose. Copal spacem is a newPMMAbone cement for fabricating spacers.This study compares elution of gentamicin, elution of
vancomycin, and compressive strength of Copal spacem and of Palacos R+G at different vancomycin loadings in the powder of
the cements. We hypothesized that antibiotic elution of Copal spacem is superior at comparable compressive strength. Methods.
Compression test specimens were fabricated using Copal spacem manually loaded with 0.5 g gentamicin and additionally 2 g,
4 g, and 6 g of vancomycin per 40 g of cement powder (COP specimens) and using 0.5 g gentamicin premixed Palacos R+G
manually loaded with 2 g, 4 g, and 6 g of vancomycin per 40 g of cement powder (PAL specimens). These specimens were used for
determination of gentamicin and vancomycin elution (in fetal calf serum, at 22∘C) and for determination of compressive strength
both prior and following the elution tests.Results. Cumulative gentamicin concentrations (p< 0.005) and gentamicin concentration
after 28 days (p ≤ 0.043) were significantly lower for COP specimens compared to PAL specimens. Cumulative vancomycin
concentrations were significantly higher (p ≤ 0.043) for COP specimens after the second day. Vancomycin concentrations after
28 days were not significantly higher for the Copal specimens loaded with 2 g and 4 g of vancomycin. Compressive strength was
not significantly different between COP specimens and PAL specimens before elution tests. Compressive strength after the elution
tests was significantly lower (p = 0.005) for COP specimens loaded with 2 g of vancomycin. Conclusion. We could not demonstrate
consistent superior antibiotic elution from Copal spacem compared to Palacos R+G for fabricating gentamicin and vancomycin
loaded spacers.The results do not favor Copal spacem over PalacosR+G for the use as a gentamicin and vancomycin biantibiotic-
loaded spacer.
1. Introduction
Antibiotic-loaded bone cements are used to fabricate spacers
during two-stage exchange of knee and hip prostheses for
the treatment of periprosthetic joint infection (PJI) [1]. Dur-
ing stage-one operation, the infected prosthesis is removed
and a poly(methyl methacrylate) (PMMA) bone cement
spacer is temporarily implanted. The spacer works as a
drug delivery system for antibiotics in order to achieve high
local concentrations [2]. Additionally, it stabilizes the joint
during mobilization and prevents soft tissue contraction [3].
Antibiotic loading of the bone cement can be performed right
before the mixing procedure (manually loaded) or during the
industrial production of the powder component (premixed).
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Table 1: Compositions of powder of the prepared specimen groups.
Specimen group Active gentamicin amount in g Active vancomycin amount in g
Pal2 0.5 2.0
Pal4 0.5 4.0
Pal6 0.5 6.0
Cop2 0.5 2.0
Cop4 0.5 4.0
Cop6 0.5 6.0
The spacer is molded after initiation of the polymerization of
the cement by mixing its powder and liquid.
To date, some bone cement brands that are intended
for the use for fixation of total joint replacements are
also used to fabricate spacers, one example being Palacos
R+G [4, 5]. At the same time, cement modifications with
improved antibiotic elution are tested [6]. Recently, a bone
cement brand, designed specifically for fabricating spacers
(Copal spacem), was launched. The powder of this brand
includes calcium carbonate particles, which serve as both
contrast agent and biodegradable porogen. Antibiotics are
not premixed into Copal spacem, with the intention that
an appropriate amount of pathogen-adjusted antibiotic will
be mixed with the powder of the cement just before spacer
fabrication and implantation. Bitsch et al. reported improved
antibiotic elution characteristics of Copal spacem when a
single antibiotic was added [7]. In vitro testing has shown
that combination of antibiotics in a spacer can induce syner-
gistic antibiotic elution [2] and superior antibacterial effects
[8–10]. The combination of gentamicin and vancomycin
ensures effective action against a broad range of PJI-causing
pathogens [11]. Thus, there are reports of clinical use of
spacers fabricated using manual loading of the gentamicin
premixed powder of Palacos R+G with vancomycin [1,
4].
In the present study, we compared antibiotic elution and
compressive strength of Copal spacem when gentamicin
and vancomycin were added (COP specimens) to those
properties for Palacos R+G when vancomycin was added
(PAL specimens). For COP, the amount of gentamicin added
is the same as it is premixed in Palacos R+G. For both
cements, the antibiotic(s) were added to the powder using
manual mixing. The investigation involved determination of
the influence of vancomycin loading on the aforementioned
cement properties and the compression tests were run both
prior to and following the end of the elution tests. We
hypothesized that gentamicin and vancomycin elution from
COP specimens are significantly higher than from PAL
specimens at comparable compressive strengths.
2. Materials and Methods
2.1. Specimen Preparation. Palacos R+G (Heraeus Medical
GMBH, Germany) contains premixed 0.8 g gentamicin sul-
phate (0.5 g active gentamicin). To produce equal gentamicin
loading, 0.84 g gentamicin sulphate (0.5 g active gentamicin)
(Caelo, Germany) was added to the powder of Copal
spacem (40 g) (Heraeus Medical GMBH, Germany). Then
2.05 g, 4.10 g, and 6.15 g vancomycin hydrochloride (Hikma
Farmaceutica, Portugal) were added to the powder of Copal
spacem. The same amounts of vancomycin hydrochloride
were added to the powder of Palacos R+G. Thus, 6 cement
formulations were used (Table 1).
Manual loading was performed following the recom-
mendations by Kuhn et al. The antibiotics were thoroughly
ground in a mortar and then the cement powder was
successively added while stirring [4]. After that, the mixture
was combined with the liquid of the cement, to produce a
dough which then was poured into a mold to yield short,
cylindrical specimens (diameter and height = 6 mm and 12
mm, respectively). These specimens were used for both the
elution and the compression tests.
2.2. Elution Tests. The specimen was immersed in 1.5 ml
fetal calf serum (FCS), in ambient laboratory conditions
(temperature = 22 ± 1∘C) for four weeks. FCS was exchanged
every 24 hours. Samples of the eluate were taken every
24 hours for the first 7 days as well as after 14 and 28
days and stored at -20∘C for determination of antibiotic
concentration.Vancomycin concentrationsweremeasured in
a clinical analyzer (Hitachi Analyzer, Roche,Germany)with a
homogene enzyme immunoassay (Online TDMVancomycin
Cobas, Roche (upper limit of measurement 50.0 𝜇g/ml
and lower limit of measurement 5.0 𝜇g/ml with coefficient
of variance 1.1%–4.9%)). Gentamicin concentrations were
measured in the same way with the CEDIA Gentamicin II
Assay (Microgenics, Germany (upper limit of measurement
12.0 𝜇g/ml and lower limit of measurement 0.00 𝜇g/ml
with coefficient of variance 3.0–6.2% for gentamicin)). If the
concentration exceeded the upper limit of measurement, the
eluate was diluted with FCS, the measurement was repeated,
and the true concentration was calculated. For each of the
formulations, 6 specimens were tested.
2.3. Compression Tests. The tests were conducted in accor-
dance with the ISO 5883 [12] using a servohydraulic material
testing machine (Z020, Zwick/Roell, Ulm, Germany), at a
crosshead displacement of 10mm/min. Tests were performed
on two sets of specimens, prior to (n = 5) and immediately
following the end of the elution test (n = 5).
2.4. Statistical Analysis. Results are presented as mean and
95% confidence intervals. TheKolmogorov-Smirnov-test was
used to determine normal distribution of variables. Levene’s
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Figure 1: Cumulative gentamicin concentrations in FCS sorted by
specimen group. Continuous line: vancomycin amount 6g; dotted
line: vancomycin amount 4g; far dotted line: vancomycin amount 2g;
asterisks: Cop6; pentagons: Pal6; circles: Cop4; ellipses: Pal4; double
triangles: Cop2; triangles: Pal2; whiskers: 95% confidence intervals.
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Figure 2: Cumulative vancomycin concentrations in FCS sorted by
specimen group. Continuous line: vancomycin amount 6g; dotted
line: vancomycin amount 4g; far dotted line: vancomycin amount 2g;
asterisks: Cop6; pentagons: Pal6; circles: Cop4; ellipses: Pal4; double
triangles: Cop2; triangles: Pal2; whiskers: 95% confidence intervals.
test was used to test for equality of variances. T-tests for
independent values were performed to identify significant
differences in means. Significance was indicated if p < 0.05.
All of these tests were performed using a commercially-
available software package SPSS 24.0 (SPSS Inc., USA).
3. Results
TheCOP specimens produced significantly lower cumulative
gentamicin concentrations than the PAL specimens at each of
the 9 time points (p ≤ 0.005) (Figure 1).
The Cop2 specimens produced significantly higher (p
≤ 0.043) cumulative vancomycin concentrations after day
2. For the Cop4 specimens significantly higher (p ≤ 0.035)
cumulative vancomycin concentrations were measured after
day 1 and for the Cop6 specimens at every measurement
(p ≤ 0.004). Figure 2 depicts the cumulative vancomycin
concentrations
Long term elution is crucial for the treatment with spac-
ers. Table 2 depicts the determined antibiotic concentrations
after 28 days.
Compressive strengths before elution tests were below the
ISO 5883 recommended 70 MPa threshold, except for Pal4
(Table 3).
After the elution tests, the compressive strength of Cop2
was significantly lower (p = 0.005) than of Pal2.The compres-
sive strength of the COP and the PAL specimens loaded with
4 g and 6 g of vancomycin underwent significant reduction
(p ≤ 0.014) during antibiotic elution.
4. Discussion
Antibiotic-loaded PMMA bone cements are used as spac-
ers to provide high local antibiotic concentrations and
mechanical stability of the affected joint after removal of
the infected prosthesis [2]. The bone cement Copal spacem
was recently introduced as a cement designed specifically for
high antibiotic elution. However, data on antibiotic elution
and mechanical properties of the Copal spacem cement
are lacking. The current study compared antibiotic elution
and compressive strength of Copal spacem and of Palacos
R+G as biantibiotic cements loaded with gentamicin and
vancomycin.
For these biantibiotic formulations, we found lower
gentamicin elution of the manually blended Copal spacem
compared to the gentamicin premixed Palacos R+G. In
contrast, Bitsch et al. found superior cumulative antibiotic
elution from Copal spacem in comparison to Palacos R,
when both these cements were manually monoantibiotic-
loaded with gentamicin. In their study, vancomycin release
displayed a slope of the cumulative antibiotic concentrations,
which leveled earlier with decreasing amount of added
vancomycin [7]. In accordance with these results, we found
significant higher cumulative elutions but not higher van-
comycin concentrations after 28 days for Cop2 and Cop4.
In the current investigation, manually gentamicin and
vancomycin loaded Copal spacem was compared to com-
mercially available gentamicin premixed Palacos R+Gman-
ually blended with vancomycin. Elution of Copal spacem
is enhanced by addition of calcium carbonate as a soluble
porogen [7]. Such porogens enhance antibiotic elution by
pore formation [6]. Although controversially discussed [13–
15], premixed antibiotics are reported to be better eluted than
manually loaded antibiotics [8, 16]. Ferraris et al. found larger
inhibition zones around Palacos R+G specimens com-
pared to manually gentamicin loaded Palacos R specimens,
indicating higher antibiotic elution [8]. Comparable results
were presented in the study by Lewis et al. demonstrating
higher antibiotic elution from industrial loaded cements
compared to manually loaded cements [17].Thus, the elution
enhancing effect of calcium carbonate in Copal spacem
did not compensate for the weaker elution of the manually
loaded gentamicin compared to the premixed gentamicin.
For the manually loaded vancomycin, the elution enhancing
effect of calcium carbonate in Copal spacem leads to higher
cumulative antibiotic elution by increasing the initial burst
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Table 2: Comparison of determined antibiotic concentrations after 28 days sorted by specimen group and measured antibiotic.
Specimen group by amount
of added vancomycin in g Measured antibiotic
Antibiotic concentration
for COP
mean in 𝜇g/ml (CI 95%)
Antibiotic concentration
for PAL
mean in 𝜇g/ml (CI95%)
p
2 Gentamicin 2.46 (2.03 – 2.91) 5.21 (2.62 – 7.80) 0.041
4 Gentamicin 2.97 (2.35 – 3.59) 4.93 (3.84 – 6.03) 0.002
6 Gentamicin 2.53 (2.02 – 3.03) 4.08 (2.43 – 5.73) 0.043
2 Vancomycin 5.52 (5.01 – 6.02) 5.52 (3.45 – 7.59) 1.000
4 Vancomycin 12.03 (11.19 – 12.88) 12.82 (6.80 – 18.84) 0.754
6 Vancomycin 17.73 (15.92 – 19.55) 11.45 (8.41 – 14.49) 0.001
Table 3: Comparison of compressive strengths before and after elution tests sorted by specimen group.
Specimen
group
Compressive strength before
elution mean MPa (95% CI)
Comparison of groups Compressive strength after
elution mean MPa (95% CI)
before vs. after
elution pbefore elution tests p after elution tests p
Pal2 69.4 (66.8 – 72.0) 0.193 0.005 70.4 (67.3 – 73.2) 0.486
Cop2 66.9 (62.6 – 71.1) 63.9 (60.1 – 67.7) 0.173
Pal4 70.7 (65.5 – 76.0) 0.637 0.805 59.8 (57.5 – 62.1) 0.001
Cop4 69.5 (64.6 – 74.4) 60.1 (57.0 – 63.2) 0.002
Pal6 67.7 (58.2 – 77.1) 0.461 0.279 57.7 (53.8 – 61.6) 0.014
Cop6 65.1 (62.5 – 67.7) 55.5 (52.1 – 59.0) < 0.000
release of vancomycin. However, high initial vancomycin
elution goes along with enhanced vancomycin depletion.
Consequently, the effect of improved vancomycin release by
Copal spacem fades by time in dependence of the amount
of added antibiotic.
Compressive strength was reduced irrespectively of the
amount of added antibiotic without significant differences
between the COP and the PAL groups before the elution tests.
After the elution tests, reduction of compressive strength
was caused by void and crack formation due to antibiotic
elution of the manually loaded antibiotics [18]. Beyond a
critical antibiotic concentration, antibiotic elution leads to the
development of a mechanically relevant percolation network
causing significant reduction of compressive strength [16]. In
our study, the specimens of both groups with 4 g and 6 g of
vancomycin exceeded this critical antibiotic concentration.
However, although the absolute amounts of antibiotics in the
cement powders were the same for the corresponding groups,
COP specimens had a higher proportion of manually added
antibiotic than PAL specimens.The difference in compressive
strength of the 2 g vancomycin groups shows that the critical
antibiotic concentration of the manually added antibiotics
for mechanically relevant percolation lies between Cop2 and
Pal2.
The current study has a number of limitations. We exam-
ined antibiotic release by determination of concentrations,
which does not allow conclusion on antimicrobial activity.
Thus, we cannot state whether the higher antibiotic burst
release of vancomycin from COP specimens is of advantage
compared to the concentrations produced by PAL speci-
mens. All measured concentrations exceeded the minimal
inhibitory concentration of the most common pathogens for
PJI, even after 28 days [19, 20]. After this time, antibiotic
measurements were stopped, because concentrations fell
below the lower limit of measurement for vancomycin. In
contrast to antimicrobial testing, determination of concen-
trationswas chosen for better comparability and themeasure-
ment method for its very low coefficient of variance. Further-
more, our study was limited to the antibiotics gentamicin and
vancomycin. Other combinations need to be investigated, but
the chosen combination is in clinical use [1, 4]. Finally, Copal
spacem has shown better wear behavior compared to Pala-
cos R in vitro [7]. This could reduce wear particle induced
osteolysis, whenused to fabricate articulating spacers. Copal
spacemmight be advantageous for the treatment of PJI with a
known pathogen as monoantibiotic-loaded spacer. However,
if the pathogen is unknown, a biantibiotic-loaded spacer
with vancomycin covering a broad spectrumof gram-positive
and gentamicin covering a broad spectrum of gram-negative
pathogens is warranted [11]. Our results are specifically
relevant for this indication. For neither Copal spacem nor
Palacos R+G, the addition of 4 g and 6 g of vancomycin can
be recommended due to mechanical considerations [2, 21–
23]. For the addition of 2 g of vancomycin, we found a
higher initial burst release of vancomycin, but no significant
difference of concentrations after 28 days. Additionally, sig-
nificantly lower gentamicin concentrations were determined
for Copal spacem throughout the study. Based on these in
vitro results, Copal spacem is not of advantage for the use
as a gentamicin and vancomycin biantibiotic-loaded, static
spacer in comparison to Palacos R+G.
5. Conclusion
Copal spacem demonstrated inferior gentamicin elution.
Cumulative vancomycin elution was significantly higher for
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all COP specimens, whereas vancomycin concentrations
after 28 days showed no relevant differences. We could
not demonstrate consistent superior antibiotic elution from
Copal spacem in comparison to Palacos R+G as a biantibi-
otic gentamicin and vancomycin loaded cement. Thus, our
results do not favor Copal spacem over Palacos R+G for
gentamicin and vancomycin biantibiotic-loaded spacers.
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